Ohmx

About:

Ohmx is a clinical diagnostics company developing a bio-electronic point-of-care system to quantify analytes from biological samples.

Website: http://ohmxbio.com

Description:

Ohmx is a clinical diagnostic company that is developing a low-cost, bioelectronic, Point-Of-Care (POC) system that quantifies analytes from a low-volume biological sample (e.g. whole blood, urine, semen, prostatic fluid, etc). Ohmx’s market entry strategy is based on a portable analyzer to assist clinicians with the diagnosis and monitoring of patients with chronic diseases in the POL (physician office lab) setting.The Ohmx POC device will enable doctors to quickly and cost-effectively diagnose, monitor and better manage patients with chronic diseases. The company’s initial focus is on the diabetes market, starting with a POC Hemoglobin A1c test using a fingerstick blood sample.

Total Funding Amount:

$9.9M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Evanston, Illinois, United States

Founded Date:

2003-01-01

Contact Email:

info(AT)ohmx.com

Founders:

Thomas J. Meade

Number of Employees:

11-50

Last Funding Date:

2012-10-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai